TATA CONSUMER PRODUCTS Management Guidance Tracker

Management reaffirmed the aspirational target of INR 1,000 crore revenue for NourishCo in FY24, despite weather headwinds.

Management remains confident of delivering INR 900-1,000 crore for NourishCo in FY24, despite Q3 being seasonally weak.

Staggered price increases have been actioned and more are planned to mitigate the 30% tea cost inflation, though full pass-through depends on competitive dynamics.

Management remains confident of 30% revenue growth for Capital Foods and Organic India in FY26, with margins in line with business case.

Price increases announced for January 2026; a second round may be needed in March to normalize margins, subject to coffee cost and tariff evolution.

Management expects consolidated revenue to grow at double digits, with EBITDA growth ahead of revenue.

Management reiterated the long-term aspiration of 30% growth for Tata Sampann, though Q2 exceeded this at 47%.

Innovation contributed 5.5% in Q2, and management guided for a full-year innovation contribution of 5%.

With the addition of Capital Foods and Organic India, management targets growth businesses to contribute 30% of India business, growing at 30%.

With Capital Foods and Organic India, growth businesses (NourishCo, Soulfull, etc.) are expected to account for 30% of India revenue and grow at 30%.

Management reiterated commitment to grow the growth businesses (including acquisitions) from 20% to 30% of the India portfolio, with these businesses growing at 30% CAGR.

After re-indexing pricing on Tata Gluco+, management expects the ready-to-drink business to resume its normative growth trajectory by the end of the current quarter.

The company is on track to deliver innovation as a percentage of sales above 5% for the full year, with Q2 at 4.1%.

After stabilization, focus shifts to accelerating growth with innovation and expansion into food services and pharma channels, expecting a substantial jump in Q4.

Target for growth businesses (Sampann, Soulfull, etc.) to grow at 30% and contribute 30% of portfolio; currently at 27% contribution with 89% growth.

Sampann, Soulful, and other growth businesses are expected to continue growing at ~30% annually, maintaining their 30% revenue contribution target.

NourishCo, Capital Foods, and Organic India are expected to return to 30%+ growth from Q2 FY26.

The 30% of portfolio growing at 30% is expected to sustain in the near term, driven by low penetration and distribution expansion.

Management expects growth businesses (Sampann, RTD, etc.) to maintain around 30% growth, though quarterly variations may occur.

Advertising and promotion spend will be in the 7.5-8.5% range going forward, up from 6.7% in FY26.

Growth businesses (Sampann, NourishCo, Capital Foods, Organic India) expected to continue growing at around 30% in the near term.

Management expects to complete the merger of Tata Coffee business within the current financial year, pending NCLT approvals.

The rights issue process is on track and expected to conclude by early Q2 FY25.

Management committed to completing the integration of Organic India within 100 days from the April 16 closure, and is on track.

Integration of Capital Foods, including channel inventory cleanup, is complete and run rate is trending as expected.

The rights issue, expected to close on August 19, will be used to repay short-term bridge financing of INR 3,000 crore raised for acquisitions.

Management plans to step up advertising spend from current ~7% to 7.5-8% in the short to medium term.

Capital Foods front-end integration substantially complete; Organic India expected to close in 45-60 days, with full integration within 100 days.

Capital Foods acquisition closed Feb 1, integration targeted for completion by end of April (100 days). 95% of distributors already billing.

Organic India acquisition closed April 16, integration targeted for completion in 100 days.

Piloted in 10 cities, pharma channel to expand to 40 cities next year, driving significant uplift for Organic India.

Management expects international business margins to improve and become accretive to overall margins, with U.S. showing progress in 6-12 months.

Management reiterated commitment to improving EBITDA margins year-on-year, supported by new acquisitions and operating leverage, though near-term tea cost volatility is a watch-out.

Management expects Q3 to be the peak of tea margin pressure, with gradual improvement as price hikes flow through and new crop arrives in Q1 FY26.

Management expects EBITDA margins to normalize to ~16% as tea costs soften with a normal crop, with recovery starting by end of Q2 FY26.

Management expects consolidated EBITDA margin to reach 16% by Q3 as lower-cost tea inventory flows in.

Management expects to reach ~15% EBITDA margin by Q4, implying 130-160 bps expansion from current 13.6%, barring coffee cost headwinds.

Tea gross margins will be maintained at 34%-36% to balance profitability and market share; pricing adjustments will be made as needed.

Management expects to exit Q4 with EBITDA margins in the 14.5-15% range, driven by scale and portfolio mix.

Over the longer term, management targets EBITDA margins above 17% for the India foods business.

US coffee price increases have been passed on; margins expected to normalize in about one quarter.

Full-year EBITDA margin expected to expand by 50-75 basis points over FY26, despite A&P normalization.

Capex for FY26 will be similar to FY25 levels, with no significant new investments; Vietnam capex continues into H1 FY26.